The Partnership for Safe Medicines--India: Lessons for Partnerships in Emerging Markets.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 36, doi. 10.5912/jcb572
- By:
- Publication type:
- Article
Works matching IS 14628732 AND DT 2012 AND VI 18 AND IP 4
Results: 14
1
2
Lessons on emerging markets and global health.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 34, doi. 10.5912/jcb563
- By:
- Publication type:
- Article
3
CROs in Modern-day China.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 19, doi. 10.5912/jcb548
- By:
- Publication type:
- Article
4
The University of California, Davis, collaborative model for biotechnology education and training.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 87, doi. 10.5912/jcb521
- By:
- Publication type:
- Article
5
Biomarketing strategy and tactics 101: Part III of III.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 75, doi. 10.5912/jcb476
- By:
- Publication type:
- Article
6
Tipping point: Biosimilars, emerging markets, and public-private engagement to promote global health.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 65, doi. 10.5912/jcb562
- By:
- Publication type:
- Article
7
Globalization, evolution and emergence of direct-to-consumer advertising: Are emerging markets the next pharmaceutical marketing frontier?
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 58, doi. 10.5912/jcb.564
- By:
- Publication type:
- Article
8
Emerging markets and differential pricing policies: A question of global health?
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 40, doi. 10.5912/jcb568
- By:
- Publication type:
- Article
9
Blood supply and safety in the developing world: Considerations for emerging markets.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 50, doi. 10.5912/jcb565
- By:
- Publication type:
- Article
10
Global health diplomacy and management mechanisms of USChina public health collaborations in China: Lessons for emerging markets.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 44, doi. 10.5912/jcb569
- By:
- Publication type:
- Article
11
Analyzing the broadening scope of patentability in the advancing field of biotechnology.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 27, doi. 10.5912/jcb573
- By:
- Publication type:
- Article
12
Biotechnology in Brazil: An industry overview.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 9, doi. 10.5912/jcb542
- By:
- Publication type:
- Article
13
Not fully harmonized: Differences in biotechnology patenting between Europe and the United States.
- Published in:
- Journal of Commercial Biotechnology, 2012, v. 18, n. 4, p. 5, doi. 10.5912/jcb549
- By:
- Publication type:
- Article
14
The birth of a discipline: Bioentrepreneurship.
- Published in:
- 2012
- By:
- Publication type:
- Opinion